Search Results - Blumer, Jeffrey
- Showing 1 - 20 results of 29
- Go to Next Page
-
1
-
2
-
3
Pediatric Infectious Disease by Blumer, Jeffrey L., Toltzis, Philip
Published 2005Text -
4
-
5
Determination of Appropriate Weight-Based Cutoffs for Empiric Cefazolin Dosing Using Data from a Phase 1 Pharmacokinetics and Safety Study of Cefazolin Administered for Surgical Pr... by Schmitz, Michael L., Blumer, Jeffrey L., Cetnarowski, Wes, Rubino, Christopher M.
Published 2015Text -
6
-
7
-
8
-
9
A Population Pharmacokinetic Modeling Approach Shows that Serum Penicillin G Concentrations Are Below Inhibitory Concentrations by Two Weeks after Benzathine Penicillin G Injection... by Neely, Michael, Kaplan, Edward L., Blumer, Jeffrey L., Faix, Dennis J., Broderick, Michael P.
Published 2014Text -
10
-
11
-
12
Comparison of Pharmacokinetics and Safety of Voriconazole Intravenous-to-Oral Switch in Immunocompromised Adolescents and Healthy Adults by Driscoll, Timothy A., Frangoul, Haydar, Nemecek, Eneida R., Murphey, Donald K., Yu, Lolie C., Blumer, Jeffrey, Krance, Robert A., Baruch, Alice, Liu, Ping
Published 2011Text -
13
Pharmacokinetic and Tolerability Assessment of a Pediatric Oral Formulation of Pentoxifylline in Kawasaki Disease() by Best, Brookie M., Burns, Jane C., DeVincenzo, John, Phelps, Stephanie J., Blumer, Jeffrey L., Wilson, John T., Capparelli, Edmund V., Connor, James D.
Published 2003Text -
14
-
15
Impact of Rifabutin or Rifampin on Bedaquiline Safety, Tolerability, and Pharmacokinetics Assessed in a Randomized Clinical Trial with Healthy Adult Volunteers by Healan, Amanda M., Griffiss, J. McLeod, Proskin, Howard M., O'Riordan, Mary Ann, Gray, Wesley A., Salata, Robert A., Blumer, Jeffrey L.
Published 2017Text -
16
Population Pharmacokinetic Model for Gatifloxacin in Pediatric Patients by Rubino, Christopher M., Capparelli, Edmund V., Bradley, John S., Blumer, Jeffrey L., Kearns, Gregory L., Reed, Michael, Jacobs, Richard F., Cirincione, Brenda, Grasela, Dennis M.
Published 2007Text -
17
Mycobactericidal activity of bedaquiline plus rifabutin or rifampin in ex vivo whole blood cultures of healthy volunteers: A randomized controlled trial by Wallis, Robert S., Good, Caryn E., O’Riordan, Mary A., Blumer, Jeffrey L., Jacobs, Michael R., Griffiss, J. McLeod, Healan, Amanda, Salata, Robert A.
Published 2018Text -
18
Effectiveness and Safety of Valsartan in Children Aged 6 to 16 Years With Hypertension by Wells, Thomas, Blumer, Jeffrey, Meyers, Kevin E.C., Neto, Jose P.R., Meneses, Rejane, Litwin, Mieczysław, Vande Walle, Johan, Solar‐Yohay, Susan, Shi, Victor, Han, Guangyang
Published 2011Text -
19
Comparison of Pharmacokinetics and Safety of Voriconazole Intravenous-to-Oral Switch in Immunocompromised Children and Healthy Adults by Driscoll, Timothy A., Yu, Lolie C., Frangoul, Haydar, Krance, Robert A., Nemecek, Eneida, Blumer, Jeffrey, Arrieta, Antonio, Graham, Michael L., Bradfield, Scott M., Baruch, Alice, Liu, Ping
Published 2011Text -
20
Single-Dose Pharmacokinetics of Intravenous Itraconazole and Hydroxypropyl-β-Cyclodextrin in Infants, Children, and Adolescents by Abdel-Rahman, Susan M., Jacobs, Richard F., Massarella, Joseph, Kauffman, Ralph E., Bradley, John S., Kimko, Hui C., Kearns, Gregory L., Shalayda, Kevin, Curtin, Christopher, Maldonado, Samuel D., Blumer, Jeffrey L.
Published 2007Text